Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 27, 2023

Impact of BMI and Comorbidities on the Efficacy of Once-Weekly Semaglutide



Additional Info

Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial
Obesity 2023 Mar 06;[EPub Ahead of Print], BM McGowan, A Houshmand-Oeregaard, PN Laursen, N Zeuthen, J Baker-Knight

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading